Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on July 12, 2006
J Am Soc Nephrol 17: 2164-2175, 2006
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2006010033

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2006010033v1
17/8/2164    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dai, C.
Right arrow Articles by Liu, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dai, C.
Right arrow Articles by Liu, Y.
Related Collections
Right arrowRelated Article

Cell Biology

Essential Role of Integrin-Linked Kinase in Podocyte Biology: Bridging the Integrin and Slit Diaphragm Signaling

Chunsun Dai*, Donna B. Stolz{dagger}, Sheldon I. Bastacky*, Rene St.-Arnaud{ddagger}, Chuanyue Wu*, Shoukat Dedhar§ and Youhua Liu*

Departments of * Pathology and {dagger} Cell Biology and Physiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; {ddagger} Genetics Unit, Shriners Hospital for Children, Montreal, Quebec, Canada; and § BC Cancer Research Centre, Vancouver, British Columbia, Canada

Address correspondence to: Dr. Youhua Liu, Department of Pathology, University of Pittsburgh, S-405 Biomedical Science Tower, 200 Lothrop Street, Pittsburgh, PA 15261. Phone: 412-648-8253; Fax: 412-648-1916; E-mail: liuy{at}upmc.edu

Received for publication January 13, 2006. Accepted for publication May 24, 2006.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
Integrin-linked kinase (ILK) has been implicated in the pathogenesis of proteinuria and congenital nephrotic syndrome. However, the function of ILK in glomerular podocyte in a physiologic setting remains unknown. In this study, a mouse model was generated in which ILK gene was selectively disrupted in podocytes by using the Cre-LoxP system. Podocyte-specific ablation of ILK resulted in heavy albuminuria, glomerulosclerosis, and kidney failure, which led to animal death beginning at 10 wk of age. Podocyte detachment and apoptosis were not observed at 4 wk of age, when albuminuria became prominent, indicating that they are not the initial cause of proteinuria. Electron microscopy revealed an early foot process effacement, as well as morphologic abnormality, in ILK-deficient podocytes. ILK deficiency caused an aberrant distribution of nephrin and {alpha}-actinin-4 in podocytes, whereas the localization of podocin and synaptopodin remained relatively intact. Co-immunoprecipitation demonstrated that ILK physically interacted with nephrin to form a ternary complex, and {alpha}-actinin-4 participated in ILK/nephrin complex formation. Therefore, ILK plays an essential role in specifying nephrin and {alpha}-actinin-4 distribution and in maintaining the slit diaphragm integrity and podocyte architecture. These results also illustrate that the integrin and slit diaphragm signals in podocytes are intrinsically coupled through an ILK-dependent mechanism.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
Defects in the glomerular filtration barrier, as manifested by proteinuria, are the principal pathologic feature of a large number of primary glomerular diseases that eventually progress to end-stage renal failure (1). Glomerular filter, a structural apparatus that consists of the fenestrated endothelium, glomerular basement membrane (GBM), and the epithelial podocyte foot processes, serves as a molecular sieve that selectively restricts the filtration of different molecules on the basis of their size, shape, and charge (13). Genetic studies have identified several podocyte proteins, such as nephrin and podocin, that are of critical importance for establishing the size-selective filtration barrier of the kidney (46). A loss-of-function mutation in the genes that encode these proteins is associated with the development of massive proteinuria and congenital nephrotic syndrome in both animal models and patients (710).

Podocytes are the specialized visceral epithelial cells that reside on GBM outside the glomerular capillaries. Foot processes of podocytes interdigitate with their neighboring counterparts and form a filtration slit that is connected by a continuous membrane-like structure known as the slit diaphragm (SD) (1,2). Increasing evidence suggests that SD is a specialized cell–cell adhesion complex that not only provides a structural foundation for the filter barrier but also participates in cell signaling that is necessary for the maintenance of podocyte function (2,11,12). Podocytes are anchored to the GBM through the {alpha}3beta1-integrin complex that is present in the sole of the foot processes. Therefore, the cell–matrix integrin signaling also is indispensable for maintaining the delicate architecture of the glomerular filtration barrier. Consistent with this, mice that lack {alpha}3-integrin are born without podocyte foot processes formation (13). However, whether the integrin and SD signals are connected in some ways in podocytes remains uncertain.

Integrin-linked kinase (ILK) is an intracellular serine/threonine protein kinase that interacts with the cytoplasmic domains of beta integrins and mediates the integrin signaling in diverse types of cell (14,15). In addition to its catalytic kinase activity, ILK is known as an adaptor protein that interacts with numerous cytoskeleton-associated proteins such as PINCH and {alpha}-parvin (14,16). It seems that ILK works in concert with its interacting partners to build multicomponent cellular machinery that is essential for its function (17,18). Dysregulation of ILK expression has been implicated in the pathogenesis of a wide variety of chronic kidney diseases, including nephrotic syndrome and diabetic and obstructive nephropathy (1923). Overexpression of ILK is observed in patients with congenital nephrotic syndrome and in glomerular podocytes of murine models of proteinuria (19), suggesting a possible connection between aberrant ILK expression and altered podocyte biology under pathologic conditions (22). However, the function of ILK in glomerular podocyte in a physiologic setting is completely unknown.

In this study, we demonstrated that selective ablation of ILK in podocytes caused an aberrant distribution of the SD protein nephrin, as well as an early foot process effacement and morphologic abnormality. These lesions resulted in heavy albuminuria, which inevitably led to podocyte detachment and apoptosis, glomerulosclerosis, kidney failure, and animal death. Furthermore, we found that ILK physically interacted with nephrin to form a ternary complex. These findings indicate that ILK is essential for podocyte biology through bridging the integrin and SD signaling.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
Mice and Genotyping
The ILK floxed mice, in which LoxP sites were inserted downstream from exons 4 and 12 at the ILK locus through homologous recombination, was described previously (24). Transgenic mice that expressed Cre recombinase under the control of a 2.5-kb fragment of the human podocin promoter (2.5P-Cre mice) were reported elsewhere (25). By mating ILK floxed mice with podocin-Cre transgenic mice, mice that were heterozygous for the ILK floxed allele were generated (genotype ILKfl/+, Cre). These mice were cross-bred to inactivate both ILK alleles by Cre-mediated excision, thereby creating conditional knockout mice in which ILK gene was specifically disrupted in glomerular podocytes (genotype ILKfl/fl, Cre). The breeding protocol also generated heterozygous littermates (genotype ILKfl/+, Cre), as well as wild-type and several control groups with different genotype (ILK+/+; ILKfl/fl; ILKf/+; ILK+/+, Cre, referred to as controls). A routine PCR protocol was used for genotyping of tail DNA samples with following primer pairs: Cre transgene, 5'-AGGTGTAGAGAAGGCACTTAGC-3' and 5'-CTAATCGCCATCTTCCAGCAGG-3', which generated a 411-bp fragment; and ILK genotyping, 5'-CAAGGAATAAGGTGAGCTTCAGAA-3' and 5'-AAGGTGCTGAAGGTTCGAGA-3', which yielded 1.3- and 1.1-kb bands for the floxed and wild-type alleles, respectively. The presence of excision products was confirmed by PCR analysis of glomerular DNA using the following primer pair: 5'-CCAGGTGGCAGAGGTAAGTA-3' and 5'-CAAGGAATAAGGTGAGCTTCAGAA-3', which gave rise to a 230-bp fragment. All animals were born normally at the expected Mendelian frequency. All control mice displayed normal phenotype. Animal experiments were approved by the Institutional Animal Care and Use Committee at the University of Pittsburgh.

Urine Albumin, Total Protein, and Creatinine Assay
Urine total protein levels were determined using a bicinchoninic acid-based protein assay kit (Sigma, St. Louis, MO) with BSA as a standard. Urine albumin was measured by using a mouse Albumin ELISA Quantitation kit, according to the manufacturer's protocol (Bethyl Laboratories, Inc., Montgomery, TX). Serum and urine creatinine was determined by a routine procedure as described previously (26).

Glomerular Isolation
Glomerular isolation was performed according to the method described elsewhere (27) with minor modifications. Briefly, mice were anesthetized by intraperitoneal injection of pentobarbital (50 mg/kg) and perfused with 8 x 107 Dynabeads M-450 (Dynal Biotech ASA, Oslo, Norway) diluted in 5 ml of PBS by the abdomen artery. After perfusion, kidneys were removed and cut into 1-mm3 pieces and digested in collagenase A (1 mg/ml) at 37°C for 30 min with gentle shaking. After digestion, the tissue was pressed gently through a 100-µm-cell strainer (BD Falcon, Bedford, MA). Glomeruli that contained Dynabeads then were gathered by using a magnetic particle concentrator. The isolated glomeruli were washed three times with cold PBS and used for subsequent studies.

Western Blot Analysis
The glomeruli that were isolated from eight mice were pooled together and lysed with RIPA buffer that contained 1% NP40, 0.1% SDS, 100 µg/ml PMSF, 1% protease inhibitor cocktail, and 1% phosphatase I and II inhibitor cocktail (Sigma) in PBS on ice. The supernatants were collected after centrifugation at 13,000 x g at 4°C for 20 min. Protein expression in isolated glomeruli was analyzed by Western blot analysis as described previously (28). The primary antibodies used were as follows: Anti-ILK (Upstate, Charlottesville, VA), anti–WT-1 (Santa Cruz Biotechnology, Santa Cruz, CA), anti–{alpha}-actinin-4 (Alexis Corp., San Diego, CA), anti-nephrin (Progen, Heidelberg, Germany), and anti–{alpha}-tubulin (Sigma).

Histology and Immunohistochemical Staining
Kidney sections were prepared at 2 µm thickness by a routine procedure. Sections were stained with hematoxylin-eosin, periodic acid-Schiff, methenamine silver-trichrome, and Masson-trichrome by standard protocol. The histologic sections were examined by a renal pathologist. The glomeruli were assessed for segmental glomerulosclerosis and global glomerulosclerosis, mesangial matrix expansion, and glomerular size. The tubules were examined for dilation by proteinaceous fluid and tubular atrophy. The interstitium was assessed for fibrosis and mononuclear inflammation. Immunohistochemical staining for WT-1 was performed using a routine protocol as described previously (28). For quantitative determination of podocyte numbers, the WT-1–positive cells were counted in at least 10 randomly chosen glomeruli under high power (x400) in each mouse. The averages of podocyte numbers per glomerulus were calculated on the basis of individual values, which were determined on four mice per group.

Terminal Deoxynucleotidyl Transferase–Mediated dUTP Nick-End Labeling Staining
Apoptotic cell death was determined by using terminal deoxynucleotidyl transferase–mediated dUTP nick-end labeling (TUNEL) staining with DeadEnd Fluorometric Apoptosis Detection System (Promega, Madison, WI), as previously reported (26). The slide was double stained with anti–WT-1 antibody (Santa Cruz Biotechnology) for the identification of podocytes. Apoptosis in glomeruli and tubulointerstitial area was counted in all glomeruli and at least 10 randomly chosen nonoverlapping high-power (x400) fields for each mouse, four mice per group (n = 4). Apoptotic podocytes (both TUNEL and WT-1 positive) were expressed as apoptotic cells per field. For a better view of kidney morphology, another set of the paraffin-embedded kidney sections were stained with DeadEnd Colormetric TUNEL System (Promega).

Electron Microscopy
Electron microscopy of kidney samples was carried out by routine procedures as described previously (29). Briefly, mouse kidneys were perfusion fixed with 2.5% glutaraldehyde in PBS by left cardiac ventricular injection and postfixed in aqueous 1% OsO4. Specimens were dehydrated through an ethanol series, infiltrated in a 1:1 mixture of propylene oxide-Polybed 812 epoxy resin (Polysciences, Warrington, PA), and then embedded. Ultrathin sections were stained with 2% uranyl acetate, followed by 1% lead citrate. Sections were observed and photographed using a JEOL JEM 1210 transmission electron microscope (TEM; JEOL, Peabody, MA). For scanning electron microscopy (SEM), kidneys were perfusion fixed in 2.5% glutaraldehyde in PBS as for TEM, dissected lengthwise, then postfixed in 1% OsO4 (30). After dehydration through an ethanol series, kidney samples were critical point-dried, mounted on aluminum stubs, sputtered with gold-coat, and examined under JEOL 6335F field emission gun scanning electron microscope.

Immunofluorescence Staining and Confocal Microscopy
Kidney cryosections were fixed with 3.7% paraformalin for 15 min at room temperature, except that methanol was used for sections that were stained with ILK. After blocking with 10% donkey serum for 30 min, the slides were immunostained with primary antibodies against ILK, nephrin, {alpha}-actinin-4, podocin (Santa Cruz Biotechnology), and synaptopodin (Progen), respectively. For ILK and {alpha}-actinin-4 staining, the Vector M.O.M. immunodetection kit (Vector Laboratories, Burlingame, CA) was used. As a negative control, the primary antibody was replaced with nonimmune IgG, and no staining occurred. Slides were viewed under a Leica TCS-SL confocal microscope. For determination of the disruptive nephrin and {alpha}-actinin-4 distribution, a semiquantitative scoring method was used. Score 0 represents no lesion, whereas 1, 2, 3, and 4 represent the disruptive redistribution of nephrin and {alpha}-actinin-4, involving <25%, 25 to 50%, 50 to 75%, and >75% of the glomerular tuft area, respectively. At least 10 randomly chosen glomeruli were evaluated for each mouse, and an average composite score was calculated. Four mice from each group were analyzed.

Immunoprecipitation
Immunoprecipitation was carried out by using an established method (31). Briefly, isolated glomeruli were lysed on ice in 1 ml of nondenaturing lysis buffer that contained 1% Triton X-100, 0.01 M Tris-HCl (pH 8.0), 0.14 M NaCl, 0.025% NaN3, 1% protease inhibitors cocktail, and 1% phosphatase inhibitors cocktail I and II (Sigma). After preclearing with normal IgG, glomerular lysates (0.5 mg of protein) were incubated overnight at 4°C with 4 µg of anti-ILK (Upstate) and anti-nephrin (Santa Cruz Biotechnology), respectively, followed by precipitation with 30 µl of protein A/G Plus-Agarose for 1 h at 4°C. The precipitated complexes were separated on SDS-polyacrylamide gels and blotted with various antibodies as indicated.

Statistical Analyses
Statistical analysis of the data was performed by using SigmaStat software (Jandel Scientific, San Rafael, CA). Comparison between groups was made using one-way ANOVA, followed by the Student-Newman-Keuls test. P < 0.05 was considered significant.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
Podocyte-Specific Disruption of ILK Gene in Mice
We generated a mouse model in which ILK gene was selectively disrupted in glomerular podocytes by mating ILK floxed mice with podocin-Cre transgenic mice (Figure 1). Mice with podocyte-specific disruption of ILK (podo-ILK–/–), as well as wild-type and several control groups, were confirmed by PCR analysis of tail genomic DNA (Figure 1B). PCR analysis of the glomerular DNA that was isolated from the podo-ILK–/– mice displayed a 230-bp band that corresponded to the excised floxed ILK allele, indicating the Cre-mediated deletion of the ILK gene (Figure 1C). Figure 1D shows the glomerular ILK protein levels in podo-ILK–/– mice and their wild-type littermates. Comparing with the controls, ILK protein level in the isolated glomeruli in podo-ILK–/– mice was reduced by approximately 40% (Figure 1D), which is consistent with the fact that podocytes only constitute a fraction of total glomerular cell population. Podocyte-specific ablation of ILK in podo-ILK–/– mice also was confirmed by immunofluorescence staining (Figure 8; see the ILK Physically Interacts with Nephrin and {alpha}-Actinin-4 section).


Figure 1
View larger version (26K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 1. Podocyte-specific ablation of the integrin-linked kinase (ILK) in mice. (A) Diagram illustrates the strategy of generating podocyte-specific ILK knockout mice. Shown is the deletion of exons 5 through 12 in the event of recombination of the ILK gene. (B) Representative picture shows PCR analysis of the genomic DNA from tail clippings. The PCR bands of wild-type (1.1 kb), floxed (1.3 kb), and Cre (411 bp) are indicated. Genotypes of representative litters are indicated. fl, ILK floxed; Cre, Cre recombinase. (C) PCR analysis shows the Cre-excised band (230 bp) in the glomeruli of podo-ILK–/– mice. (D) Western blot analysis of ILK protein expression in whole glomeruli (pooled from eight mice per group) that were isolated from the control and podo-ILK–/– mice. Glomerular lysates were immunoblotted with antibodies against ILK and {alpha}-tubulin, respectively. (E) Body weights of the podo-ILK–/– mice and their control littermates at different time points after birth. **P < 0.01 versus controls (n = 8). (F) Representative picture shows the phenotypic appearance of podo-ILK–/– mouse and its control littermate at 10 wk after birth.

 

Figure 8
View larger version (58K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 8. ILK physically interacts with nephrin and {alpha}-actinin-4 in vivo. (A through F) Co-localization of ILK and nephrin in glomerular podocyte. Representative micrographs show the staining of ILK (A and D), nephrin (B and E), and co-localization (C and F) in the control (A through C) and podo-ILK–/– mice (D through F). Arrowheads indicate the co-localization of ILK and nephrin in podocyte in normal mice. Arrows denote ILK-deficient podocyte in which nephrin distribution was disturbed in podo-ILK–/– mice. Bar = 12 µm. (G and H) Co-immunoprecipitation demonstrates the ILK/nephrin complex formation. Glomerular lysates (pooled from eight mice) were immunoprecipitated with anti-ILK or normal IgG (G) and anti-ILK or anti-nephrin (H), followed by immunoblotting with anti-nephrin. (I) Co-immunoprecipitation demonstrates the presence of {alpha}-actinin-4 in the ILK/nephrin complex in vivo. Immunocomplexes that were precipitated with anti-ILK or anti-nephrin were immunoblotted with anti–{alpha}-actinin-4 antibody. (J and K) Ablation of ILK in podocyte abolished ILK/{alpha}-actinin/nephrin interaction. Glomerular lysates from either podo-ILK–/– (ko) or control littermates (wt) were immunoprecipitated with anti-ILK and immunoblotted with either anti–{alpha}-actinin-4 (J) or anti-nephrin (K). (L) Schematic model illustrates that ILK bridges the integrin and slit diaphragm signaling. ILK functions as an adaptor protein that physically and functionally associates with slit diaphragm protein nephrin. {alpha}-Actinin-4 participates in the ILK/nephrin complex formation. Ablation of ILK disrupts ILK/nephrin complex formation and leads to an aberrant distribution of nephrin and {alpha}-actinin-4, thereby inducing podocyte foot process effacement and morphologic alterations. That is followed by albuminuria, podocyte detachment and apoptosis, glomerulosclerosis, and kidney failure.

 
We observed no difference in the body weights in podo-ILK–/– mice at 2 wk of age when compared with the control littermates (Figure 1E). However, significant reduction in body weight was found at 10 wk of age in podo-ILK–/– mice (Figure 1, E and F). This growth retardation likely resulted from the severe morbidity characterized by heavy proteinuria that developed in podo-ILK–/– mice (see below). Podo-ILK–/– mice began to die at 10 wk. The majority of podo-ILK–/– mice died of renal failure at approximately 3 to 4 mo, although a few of them survived beyond 6 mo of age.

Podocyte-Specific Ablation of ILK Leads to Heavy Proteinuria, Glomerulosclerosis, and Kidney Failure
We next determined the urine albumin levels at different time points in podo-ILK–/– mice and their control littermates. As shown in Figure 2A, urine albumin levels were dramatically elevated at 4 wk in podo-ILK–/– mice and reached to >7 mg/mg creatinine, whereas no or little urine albumin was detected at 2 wk. Albuminuria progressively deteriorated at 10 wk in podo-ILK–/– mice. Similar results were obtained when urine total protein was measured (Figure 2B). Consistent with an elevated albumin, urine protein also was significantly increased at 4 and 10 wk in podo-ILK–/– mice, respectively. Separation of urine samples by SDS-PAGE revealed that albumin was the predominant constituent of urine proteins (Figure 2C).


Figure 2
View larger version (28K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 2. Podocyte-specific ablation of ILK results in heavy albuminuria, proteinuria, and kidney dysfunction. (A) Urinary albumin levels at different time points in podo-ILK–/– mice and their control littermates. Urinary albumin data after correction to creatinine are presented as mean ± SEM. **P < 0.01 versus controls (n = 7 to 10). (B) Urinary total protein levels at different time points in podo-ILK–/– mice and their control littermates. *P < 0.05, **P < 0.01 versus controls (n = 7 to 10). (C) SDS-PAGE demonstrates urine proteins at different time points in podo-ILK–/– mice. Urine samples were separated on 10% SDS-PAGE after correction to creatinine. BSA (1 µg) was loaded onto an adjacent lane as a positive control. Samples from two individual animals per group were used. (D) Serum creatinine levels at different time points in podo-ILK–/– mice and their control littermates. **P < 0.01 versus controls (n = 7 to 10).

 
In accordance with heavy albuminuria and proteinuria, kidney function in podo-ILK–/– mice was severely impaired in an age-dependent manner. An elevation of serum creatinine levels was observed at 10 wk in podo-ILK–/– mice, compared with their control littermates (Figure 2D). However, little difference in serum creatinine levels was found at 4 wk between podo-ILK–/– mice and controls (Figure 2D), suggesting that the development of albuminuria and proteinuria precedes kidney dysfunction in podo-ILK–/– mice.

Figure 3 shows the representative micrographs of kidney sections at different time points. Kidney morphology was normal at 2 wk after birth in podo-ILK–/– mice (data not shown). At 4 wk, kidney histology remained essentially normal, when compared with the control littermates (Figure 3, A and B). However, dramatic morphologic abnormality was observed at 10 wk in the podo-ILK–/– kidney, which was characterized by primary glomerular lesions, including an enlargement of glomeruli in size, moderate to marked mesangial expansion, and segmental glomerulosclerosis to global sclerosis (Figure 3, C, F, and I). There was widespread tubular dilation distended by proteinaceous fluid and cellular debris. The interstitium contained a mild, patchy mononuclear inflammatory infiltrate, and interstitial fibrosis generally was mild (Figure 3).


Figure 3
View larger version (141K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 3. Mice that lacked ILK in podocyte developed primary glomerulosclerotic lesions in a time-dependent manner. Representative micrographs show the morphologic lesions in the podo-ILK–/– mice at different time points after birth. Kidney sections from the control littermate at 4 wk (A, D, and G) and podo-ILK–/– mice at 4 (B, E, and H) and 10 wk (C, F, and I) were subjected to periodic acid-Schiff (PAS) staining (A through C), methenamine silver-trichrome staining (D through F), and Masson's staining (G through I). Bar = 30 µm.

 
Podocyte Detachment and Apoptosis Are Not the Initial Causes of Albuminuria
Because ILK plays an important role in mediating cell–matrix adhesion and cell survival (32), we reasoned that ILK deficiency may lead to podocyte detachment and apoptosis, thereby causing proteinuria and kidney dysfunction. To test this hypothesis, we first examined the podocyte abundance in podo-ILK–/– kidney at different time points. As shown in Figure 4, podocytes in the glomeruli were readily identifiable by the nuclear staining for transcription factor WT-1. Quantitative determination revealed that there was no difference in podocyte number per glomeruli between podo-ILK–/– mice and control littermates at 2 and 4 wk, respectively (Figure 4E), suggesting a lack of podocyte depletion at the time point when albuminuria became prominent (Figure 2). This finding was supported further by measuring WT-1 abundance from the isolated glomeruli using Western blot analysis (Figure 4F). However, podocyte depletion was predominant at 10 wk in podo-ILK–/– kidney (Figure 4D). The number of podocytes per glomeruli was decreased by approximately 70%, compared with the controls. WT-1–positive podocytes were obviously detached from the GBM and easily found in the lumens of the dilated tubules. Some tubular epithelial cells occasionally were stained positively for WT-1, possibly because they endocytosed the debris or apoptotic bodies of the dead podocytes (Figure 4D).


Figure 4
View larger version (132K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 4. Podocyte depletion is a late event secondary to the development of albuminuria in mice that lack ILK in podocyte. (A through D) Representative micrographs show the podocyte abundance at 2 (B), 4 (C), and 10 wk (D) in the glomeruli of podo-ILK–/– mice and their control littermates at 4 wk (A). Kidney sections were stained with antibody against WT-1. Arrow denotes the glomerulus with a reduced podocyte number at 10 wk in podo-ILK–/– mice (D). Arrowhead indicates the WT-1–positive podocytes in the lumen of renal tubules. Bar = 25 µm. (E) Quantitative determination of the glomerular podocyte numbers at different time points in podo-ILK–/– mice and their control littermates. **P < 0.01 versus controls (n = 4). (F) Western blot analysis demonstrates a comparable glomerular WT-1 protein level at 4 wk in podo-ILK–/– mice and their control littermates. Whole glomerular lysates (pooled from eight mice) were immunoblotted with antibodies against WT-1 and {alpha}-tubulin, respectively.

 
We also assessed the podocyte apoptosis in podo-ILK–/– kidney. As illustrated in Figure 5, no apoptosis was found at 2 and 4 wk, respectively, in the kidney with podocyte-specific deficiency of ILK. At 10 wk, little or no podocyte apoptosis was found in situ in the glomeruli of podo-ILK–/– kidney (Figure 5, G through I), even though podocyte depletion was eminent at this time point (Figure 4E). Substantial apoptosis was observed in the tubulointerstitial area of the kidney at 10 wk in podo-ILK–/– mice (Figure 5, J through M). Co-staining with TUNEL and WT-1 displayed that significant podocytes were positive for TUNEL staining in the lumens of tubules at this stage, suggesting that detached podocytes underwent apoptotic death. Intriguingly, there were the WT-1–positive podocytes that were negative for TUNEL staining, indicating that these detached podocytes were still alive in the tubular lumens. Some apoptotic cells lacked WT-1 protein, indicating their origin of tubular epithelium (Figure 5L). Similar results were obtained when kidney tissues were stained by using a colormetric apoptosis detection kit (Figure 5, N through P). Together, it became clear that podocyte detachment and apoptosis are not the initial causes of proteinuria that takes place in podo-ILK–/– mice at 4 wk of age.


Figure 5
View larger version (76K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 5. Podocyte apoptosis is secondary to cell detachment in mice with podocyte-specific ablation of ILK. (A through L) Representative micrographs demonstrate apoptotic podocytes in podo-ILK–/– mice and their control littermates. Kidney sections were subjected to terminal deoxynucleotidyl transferase–mediated dUTP nick-end labeling (TUNEL) staining to identify apoptotic cells (A, D, G, and J) and WT-1 staining to recognize podocytes (B, E, H, and K). Merging of the TUNEL and WT-1 staining images is presented (C, F, I, and L). (A through C) Control littermates at 4 wk. (D through F) Podo-ILK–/– mice at 4 wk. (G through I) Podo-ILK–/– mice at 10 wk. (J through L) Tubulointerstitial area of podo-ILK–/– mice at 10 wk. Arrow indicates an apoptotic tubular cell with negative staining for WT-1, whereas arrowhead denotes WT-1–positive podocyte with negative TUNEL staining. Bar = 30 µm. (M) Quantitative determination of apoptotic podocytes in tubulointerstitial area at 4 and 10 wk in podo-ILK–/– mice and their control littermates. **P < 0.01 versus controls (n = 4). (N through P) Representative micrographs show apoptotic cells in the tubular lumens detected by colorimetric TUNEL staining at 2 (N), 4 (O), and 10 wk (P) in podo-ILK–/– mice. Arrows indicate glomeruli. Bar = 30 µm.

 
ILK Deficiency Causes an Early Podocyte Foot Process Effacement and Morphologic Abnormality
We next examined the ultrastructural alterations of the podocyte foot processes. TEM revealed an intact filtration apparatus that consisted of the fenestrated endothelial cytoplasm, GBM, and the foot processes of podocytes (Figure 6A). However, a marked alteration that was characterized by podocyte foot process effacement was observed at 4 wk in podo-ILK–/– mice (Figure 6C). The foot processes were adhered to GBM as continuous cytoplasmic processes, which led to the disappearance of the SD. It is interesting that slight foot process effacement with narrower SD occasionally was found in some areas of podocytes at 2 wk (Figure 6B), a time point when no albuminuria had been developed. This suggests that podocyte foot process effacement is an early event that precedes and/or parallels proteinuria. As expected, the foot process effacement of podocytes deteriorated at 10 wk in podo-ILK–/– mice (Figure 6D). In addition, podocyte foot processes sometimes detached from the GBM, leading to the appearance of naked GBM on the side of the Bowman space in some areas at this stage (Figure 6D, arrowhead). GBM lesions that were characterized by an increased thickness and irregular shape also were observed in some areas of the glomeruli at 4 wk in podo-ILK–/– mice.


Figure 6
View larger version (122K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 6. ILK deficiency causes podocyte foot process effacement and induces surface morphologic changes. (A through D) Representative electron micrographs demonstrate the ultrastructural alterations in the glomerular filtration barrier at different time points after selective ablation of ILK in podocyte. (A) Control littermates at 4 wk. (B) Podo-ILK–/– mice at 2 wk. (C) Podo-ILK–/– mice at 4 wk. (D) Podo-ILK–/– mice at 10 wk. Arrow indicates fused foot processes, whereas arrowhead denotes naked GBM. CL, capillary lumen; BS, Bowman space. Bar = 0.5 µm. (E and F) Scanning electron microscopy shows the surface morphology of glomeruli at 4 wk in podo-ILK–/– mice (F) and their control littermates (E). Massive microvilli were developed in the surface of podocytes that lacked ILK. FP, foot processes. Bar = 5 µm. Microvilli-like structures also were revealed by transmission electron microscopy (arrowhead; G). Bar = 1 µm.

 
We also examined the three-dimensional structure and topography of the glomerular podocytes in podo-ILK–/– mice by SEM. As shown in Figure 6, ablation of ILK caused a significant change in podocyte surface morphology. Compared with controls, the podocytes that lacked ILK developed massive microvilli-like structures (Figure 6F), which were confirmed by TEM (Figure 6G).

Podocyte-Specific Ablation Results in Aberrant Distribution of Nephrin and {alpha}-Actinin-4
In light of a possible connection between ILK and the SD integrity, we further examined the potential alterations in the abundance and distribution of the SD proteins in podo-ILK–/– kidney. As shown in Figure 7, an aberrant distribution of nephrin was observed at 4 wk in the glomeruli of the mice that lacked ILK in podocytes, compared with their control littermates. In normal glomeruli, nephrin staining revealed a linear pattern along the GBM, corresponding to its localization in the SD between the foot processes of the podocytes (Figure 7A). However, ILK deficiency caused an altered distribution of nephrin from the SD to the entire body of podocytes, resulting in a granular staining pattern (Figure 7B), as illustrated by confocal immunofluorescence microscopy. Quantitative determination exhibited that such lesions in nephrin distribution took place in almost all glomeruli of podo-ILK–/– mice at 4 wk with different degrees of severity, although little redistribution of nephrin was observed at 2 wk (Figure 7C). The abundance of nephrin in podo-ILK–/– mice remained comparable to that in control littermates (Figure 7D). Therefore, it seems that the specific subcellular localization of nephrin depends on the presence of ILK in podocytes.


Figure 7
View larger version (46K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 7. ILK deficiency results in aberrant distribution of nephrin and {alpha}-actinin-4 in podocyte. Confocal immunofluorescence microscopy demonstrates the distribution of nephrin (A and B) or {alpha}-actinin-4 (E and F) in the glomeruli of podo-ILK–/– mice at 4 wk (B and F) and their control littermates (A and E). Boxed areas were enlarged and presented. Arrowheads indicate the staining pattern. Quantitative data on the disruptive nephrin and {alpha}-actinin-4 redistribution in podo-ILK–/– mice at 2 and 4 wk are presented in C and G, respectively. **P < 0.01 (n = 4). (D and H) Western blot analysis shows a comparable protein abundance of nephrin (D) or {alpha}-actinin-4 (H) in podo-ILK–/– mice and their control littermates. Glomerular lysates (pooled from eight mice) from mice at 4 wk were immunoblotted with specific antibodies against nephrin, {alpha}-actinin-4, and {alpha}-tubulin, respectively. Little difference was observed in the localization of podocin (I and J) and synaptopodin (K and L) in podo-ILK–/– mice (J and L) and their control littermates (I and K) at 4 wk. Bar = 10 µm.

 
We also investigated the abundance and distribution of {alpha}-actinin-4, an actin-associated protein that links the SD to actin cytoskeleton. Although there was no difference in its cellular abundance (Figure 7H), {alpha}-actinin-4 distribution underwent drastic changes in the podocytes that lacked ILK (Figure 7, E and F). The {alpha}-actinin-4 also displayed a linear staining along the GBM in normal podocytes, a pattern similar to nephrin, podocin, and other SD proteins. However, ILK deficiency caused an aberrant distribution of {alpha}-actinin-4 characterized by forming large, aggregated dots (Figure 7F). This disturbed localization of {alpha}-actinin-4 began to occur at 4 wk in podo-ILK–/– mice (Figure 7G). Under the identical conditions, the localization of podocin and synaptopodin was largely unaffected by ablation of ILK in podocytes (Figure 7, I through L), suggesting the specificity of the interplay among ILK, nephrin, and {alpha}-actinin-4.

ILK Physically Interacts with Nephrin and {alpha}-Actinin-4
The finding that ILK deficiency resulted in nephrin redistribution prompted us to explore their intrinsic connection. Double immunofluorescence staining exhibited a co-localization of ILK and nephrin in glomerular podocytes in vivo. In normal glomeruli, ILK localization within the podocytes displayed a linear pattern along the GBM (Figure 8A), similar to that of nephrin (Figure 8B). Merging of ILK and nephrin images revealed a clear co-localization in podocytes (Figure 8C). In the glomeruli of podo-ILK–/– mice, ILK was ablated specifically in podocytes (Figure 8D, arrow), whereas its expression in the mesangium was intact (Figure 8D). Deficiency of ILK in podocytes led to a diffused distribution of nephrin from the SD to the entire cell body (Figure 8E, arrow).

We examined the potential interaction between ILK and nephrin in the glomeruli by co-immunoprecipitation. As shown in Figure 8, G and H, nephrin was readily detected in the complex that was precipitated by anti-ILK antibody. As a negative control, no nephrin was detected when the glomerular lysates were precipitated with normal IgG (Figure 8G, lane 2). Likewise, podocyte-specific ablation of ILK abolished the interaction between ILK and nephrin (Figure 8K). These results suggest that ILK physically interacts with the SD protein nephrin in vivo.

We next investigated the potential involvement of {alpha}-actinin-4 in the formation of ILK/nephrin complex, because ILK ablation also disturbs its localization. As shown in Figure 8, I and J, {alpha}-actinin-4 also was detected easily in the complex that was precipitated by either anti-ILK or anti-nephrin antibodies. Ablation of ILK in podocytes largely abolished the interaction between ILK and {alpha}-actinin-4 (Figure 8J). The weak band of {alpha}-actinin-4 that was detected in the immunocomplexes likely was caused by the contamination of other cell types such as tubular cells in the glomerular preparation from the podo-ILK–/– mice (Figure 8J). Double immunofluorescence staining also revealed that {alpha}-actinin-4 co-localized with nephrin and ILK in glomerular podocytes in vivo (data not shown). Therefore, {alpha}-actinin-4 participates in the ILK/nephrin complex formation and perhaps functions as an adaptor protein bridging ILK and nephrin (Figure 8L).


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
The SD of podocyte foot processes is a pivotal component of the glomerular filtration barrier, and disruption of its integrity represents a key event in the development of proteinuria and nephrotic syndrome in a variety of inherited and acquired glomerular diseases (1,2,33). Previous studies largely focused on elucidating the role of various SD proteins such as nephrin and podocin in the SD function and glomerular filter integrity (5,6,8,10). Not surprising, mutations or deletion of these SD proteins lead to the development of congenital nephrotic syndrome. In this study, we found that selective ablation of ILK in podocyte causes heavy proteinuria, podocyte detachment and apoptosis, glomerulosclerosis, and kidney failure. The underlying mechanism of these pathologic manifestations seems to be attributable to a disturbance of nephrin localization and foot process effacement. More important, we have uncovered that ILK can physically interact with nephrin, which provides direct evidence that the integrin signaling is intrinsically linked to SD function in podocytes. These findings not only underscore an essential role of ILK in podocyte biology in normal physiologic setting but also suggest that a dysregulation of ILK abundance and/or activity potentially may play a critical role in the development of proteinuria and podocyte dysfunctions. Because the integrin/ILK signaling is regulated by many extracellular cues, such as matrix components, high glucose, growth factors, and cytokines, the intrinsic connection of ILK with nephrin that was unraveled in this study offers important insights into understanding the pathogenesis of proteinuria in many common glomerular diseases, such as diabetic nephropathy. Therefore, our study may have wide implications in comprehending how alterations in the extracellular environment lead to defects in SD function and impairment of glomerular filtration.

The finding that ILK binds to nephrin defines a novel, physiologically important interacting partner for ILK. By interacting with the cytoplasmic domains of beta-integrins and nephrin, ILK virtually acts as an adaptor or scaffolding protein that bridges and integrates the integrin and the SD signals. Physical interaction between ILK and nephrin is clearly evident in the glomeruli of normal kidney in vivo, as demonstrated by co-immunoprecipitation (Figure 8). Whether ILK binds to nephrin directly or via additional adaptor proteins, however, remains uncertain. In this aspect, it is interesting to note that {alpha}-actinin-4 was involved in the ILK/nephrin complex formation, suggesting the presence of a multicomponent ternary complex in which ILK likely is a central element. We propose that the coupling of ILK to nephrin likely is mediated by additional proteins such as {alpha}-actinin-4 (Figure 8L). Further studies are warranted in this area to characterize fully the molecular details of the ILK/nephrin interaction in podocyte.

Given the physical interaction between ILK and nephrin, it is not difficult to understand that ablation of ILK causes a redistribution of nephrin, resulting in a diffused pattern throughout the podocytes in podo-ILK–/– mice. In the absence of ILK, nephrin would lose its anchoring sites for proper trafficking and localization to the SD. This underscores that ILK may be essential for specifying nephrin distribution in podocytes, possibly by acting as an anchoring apparatus. It is worthwhile to point out that in many glomerular diseases, such as diabetic nephropathy, redistribution and reduction of nephrin are predominant pathologic features in podocytes (3436). Although the exact mechanism remains elusive, dysregulation of ILK abundance and/or activity, which is common in chronic kidney diseases, may play a significant role in causing nephrin redistribution in these conditions.

Another striking feature in ILK-deficient podocyte is the aberrant distribution of {alpha}-actinin-4, an actin cross-linking protein that binds to actin filaments (37,38). Genetic mutations in {alpha}-actinin-4 gene have been shown to cause an autosomal dominant focal segmental glomerulosclerosis in patients (39). In normal glomeruli, the pattern of {alpha}-actinin-4 distribution essentially resembles that of SD proteins such as nephrin and podocin, consistent with its close association with the SD. Similar to nephrin, selective ablation of ILK in podocyte causes {alpha}-actinin-4 redistribution, indicating that ILK also directs {alpha}-actinin-4 localization. This notion is corroborated further by {alpha}-actinin-4's binding to ILK and nephrin (Figure 8). The complex interactions among ILK, nephrin, and {alpha}-actinin-4 virtually connect the integrin and the SD with the actin cytoskeleton and integrate both extracellular and intracellular signals from multiple directions.

Our study also strengthens the notion that the disorganization of actin cytoskeleton may play a critical role in the development of podocyte foot process effacement and structural abnormality. In ILK-deficient podocyte, {alpha}-actinin-4 forms aggregated dots (Figure 7F). Such mislocalization of {alpha}-actinin-4 certainly would change the actin cytoskeleton dynamics (40) and may cause the collapse of the actin meshwork underneath or near the SD of the foot processes. Because actin cytoskeleton defines cell shape and morphology, altered cytoskeletal structure of the foot processes will lead to disappearance of the SD structures and development of an "effaced" phenotype, as demonstrated by electron microscopy studies (Figure 6). This speculation also is supported by the observations that mutations or deletion of {alpha}-actinin-4 gene cause proteinuria and focal segmental glomerulosclerosis in both animal models and patients (39,41,42). Because no alteration in {alpha}-actinin-4 level was seen in podocytes that lacked ILK, this suggests that not only the quality (mutations) and the quantity (deletion or induction) of {alpha}-actinin-4 but also its location are of extreme importance in maintaining the integrity of the podocyte architecture. Furthermore, massive microvilli-like structures developed in ILK-deficient podocytes, illustrating that the submembranous actin skeleton architecture is profoundly changed.

ILK has been implicated in the regulation of cell adhesion and cell survival (43,44). However, podocyte detachment and apoptosis seem not to be the initial cause of proteinuria in the podo-ILK–/– mice, because the podocyte numbers were preserved at the time point when severe albuminuria became eminent. Nevertheless, we cannot exclude the possibility that podocyte depletion via cell detachment and apoptosis in the podo-ILK–/– mice may deteriorate the proteinuria and accelerate the kidney dysfunction. Along this line, it is conceivable that podocyte loss from 4 wk onward may play a critical role in the development of glomerulosclerosis and kidney failure that eventually lead to animal death in podo-ILK–/– mice.


    Conclusion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
We have shown herein that ILK plays an essential role in podocyte biology in vivo. Through interacting with nephrin and {alpha}-actinin-4, ILK builds a multicomponent complex that is essential for the maintenance of the podocyte function and glomerular filter integrity. Our findings have established that the cell–matrix integrin signaling and the cell–cell adhesion SD signaling are intrinsically coupled through an ILK-dependent mechanism in podocyte.


    Acknowledgments
 
This work was supported by National Institutes of Health grants DK061408, DK064005, DK071040 (Y.L.), and DK054639 (C.W.).

We sincerely thank Dr. Lawrence Holzman of the University of Michigan for kindly providing the podocin-Cre transgenic mice. We are grateful to Ana Lopez, Mara Sullivan, and Marc Rubin of the Center for Biologic Imaging for technical expertise.


    Footnotes
 
Published online ahead of print. Publication date available at www.jasn.org.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 

  1. Pavenstadt H, Kriz W, Kretzler M: Cell biology of the glomerular podocyte. Physiol Rev 83: 253–307, 2003[Abstract/Free Full Text]
  2. Benzing T: Signaling at the slit diaphragm. J Am Soc Nephrol 15: 1382–1391, 2004[Free Full Text]
  3. Tryggvason K, Wartiovaara J: Molecular basis of glomerular permselectivity. Curr Opin Nephrol Hypertens 10: 543–549, 2001[CrossRef][Medline]
  4. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K: Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome. Mol Cell 1: 575–582, 1998[CrossRef][Medline]
  5. Tryggvason K: Unraveling the mechanisms of glomerular ultrafiltration: Nephrin, a key component of the slit diaphragm. J Am Soc Nephrol 10: 2440–2445, 1999[Free Full Text]
  6. Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W, Shaw AS, Holzman LB, Mundel P: Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 108: 1621–1629, 2001[CrossRef][Medline]
  7. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24: 349–354, 2000[CrossRef][Medline]
  8. Roselli S, Heidet L, Sich M, Henger A, Kretzler M, Gubler MC, Antignac C: Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol 24: 550–560, 2004[Abstract/Free Full Text]
  9. Putaala H, Soininen R, Kilpelainen P, Wartiovaara J, Tryggvason K: The murine nephrin gene is specifically expressed in kidney, brain and pancreas: Inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 10: 1–8, 2001[Abstract/Free Full Text]
  10. Kim JM, Wu H, Green G, Winkler CA, Kopp JB, Miner JH, Unanue ER, Shaw AS: CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300: 1298–1300, 2003[Abstract/Free Full Text]
  11. Reiser J, Kriz W, Kretzler M, Mundel P: The glomerular slit diaphragm is a modified adherens junction. J Am Soc Nephrol 11: 1–8, 2000[Abstract/Free Full Text]
  12. Mundel P, Shankland SJ: Podocyte biology and response to injury. J Am Soc Nephrol 13: 3005–3015, 2002[Free Full Text]
  13. Kreidberg JA, Donovan MJ, Goldstein SL, Rennke H, Shepherd K, Jones RC, Jaenisch R: Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development 122: 3537–3547, 1996[Abstract]
  14. Wu C, Dedhar S: Integrin-linked kinase (ILK) and its interactors: A new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 155: 505–510, 2001[Abstract/Free Full Text]
  15. Hannigan G, Troussard AA, Dedhar S: Integrin-linked kinase: A cancer therapeutic target unique among its ILK. Nat Rev Cancer 5: 51–63, 2005[CrossRef][Medline]
  16. Wu C: The PINCH-ILK-parvin complexes: Assembly, functions and regulation. Biochim Biophys Acta 1692: 55–62, 2004[Medline]
  17. Wu C: PINCH, N(i)ck and the ILK: Network wiring at cell-matrix adhesions. Trends Cell Biol 15: 460–466, 2005[CrossRef][Medline]
  18. Legate KR, Montanez E, Kudlacek O, Fassler R: ILK, PINCH and parvin: The tIPP of integrin signalling. Nat Rev Mol Cell Biol 7: 20–31, 2006[Medline]
  19. Kretzler M, Teixeira VP, Unschuld PG, Cohen CD, Wanke R, Edenhofer I, Mundel P, Schlondorff D, Holthofer H: Integrin-linked kinase as a candidate downstream effector in proteinuria. FASEB J 15: 1843–1845, 2001[Free Full Text]
  20. Guo L, Sanders PW, Woods A, Wu C: The distribution and regulation of integrin-linked kinase in normal and diabetic kidneys. Am J Pathol 159: 1735–1742, 2001[Abstract/Free Full Text]
  21. Li Y, Yang J, Dai C, Wu C, Liu Y: Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 112: 503–516, 2003[CrossRef][Medline]
  22. de Paulo V, Teixeira C, Blattner SM, Li M, Anders HJ, Cohen CD, Edenhofer I, Calvaresi N, Merkle M, Rastaldi MP, Kretzler M: Functional consequences of integrin-linked kinase activation in podocyte damage. Kidney Int 67: 514–523, 2005[CrossRef][Medline]
  23. Liu Y: Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15: 1–12, 2004[Abstract/Free Full Text]
  24. Terpstra L, Prud’homme J, Arabian A, Takeda S, Karsenty G, Dedhar S, St-Arnaud R: Reduced chondrocyte proliferation and chondrodysplasia in mice lacking the integrin-linked kinase in chondrocytes. J Cell Biol 162: 139–148, 2003[Abstract/Free Full Text]
  25. Moeller MJ, Sanden SK, Soofi A, Wiggins RC, Holzman LB: Podocyte-specific expression of cre recombinase in transgenic mice. Genesis 35: 39–42, 2003[CrossRef][Medline]
  26. Dai C, Yang J, Bastacky S, Xia J, Li Y, Liu Y: Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice. J Am Soc Nephrol 15: 2637–2647, 2004[Abstract/Free Full Text]
  27. Takemoto M, Asker N, Gerhardt H, Lundkvist A, Johansson BR, Saito Y, Betsholtz C: A new method for large scale isolation of kidney glomeruli from mice. Am J Pathol 161: 799–805, 2002[Abstract/Free Full Text]
  28. Yang J, Liu Y: Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 13: 96–107, 2002[Abstract/Free Full Text]
  29. Rausa FM, Tan Y, Zhou H, Yoo KW, Stolz DB, Watkins SC, Franks RR, Unterman TG, Costa RH: Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis. Mol Cell Biol 20: 8264–8282, 2000[Abstract/Free Full Text]
  30. Brown NE, Murcia NS: Delayed cystogenesis and increased ciliogenesis associated with the re-expression of polaris in Tg737 mutant mice. Kidney Int 63: 1220–1229, 2003[CrossRef][Medline]
  31. Zhang X, Yang J, Li Y, Liu Y: Both Sp1 and Smad participate in mediating TGF-beta1-induced HGF receptor expression in renal epithelial cells. Am J Physiol Renal Physiol 288: F16–F26, 2005[Abstract/Free Full Text]
  32. Yang Y, Guo L, Blattner SM, Mundel P, Kretzler M, Wu C: Formation and phosphorylation of the PINCH-1-integrin linked kinase-alpha-parvin complex are important for regulation of renal glomerular podocyte adhesion, architecture, and survival. J Am Soc Nephrol 16: 1966–1976, 2005[Abstract/Free Full Text]
  33. Kreidberg JA: Podocyte differentiation and glomerulogenesis. J Am Soc Nephrol 14: 806–814, 2003[Free Full Text]
  34. Wernerson A, Duner F, Pettersson E, Widholm SM, Berg U, Ruotsalainen V, Tryggvason K, Hultenby K, Soderberg M: Altered ultrastructural distribution of nephrin in minimal change nephrotic syndrome. Nephrol Dial Transplant 18: 70–76, 2003[Abstract/Free Full Text]
  35. Benigni A, Gagliardini E, Tomasoni S, Abbate M, Ruggenenti P, Kalluri R, Remuzzi G: Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy. Kidney Int 65: 2193–2200, 2004[CrossRef][Medline]
  36. Wang SX, Rastaldi MP, Patari A, Ahola H, Heikkila E, Holthofer H: Patterns of nephrin and a new proteinuria-associated protein expression in human renal diseases. Kidney Int 61: 141–147, 2002[CrossRef][Medline]
  37. Saleem MA, Ni L, Witherden I, Tryggvason K, Ruotsalainen V, Mundel P, Mathieson PW: Co-localization of nephrin, podocin, and the actin cytoskeleton: Evidence for a role in podocyte foot process formation. Am J Pathol 161: 1459–1466, 2002[Abstract/Free Full Text]
  38. Sako M, Nakanishi K, Obana M, Yata N, Hoshii S, Takahashi S, Wada N, Takahashi Y, Kaku Y, Satomura K, Ikeda M, Honda M, Iijima K, Yoshikawa N: Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome. Kidney Int 67: 1248–1255, 2005[CrossRef][Medline]
  39. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, Mathis BJ, Rodriguez-Perez JC, Allen PG, Beggs AH, Pollak MR: Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 24: 251–256, 2000[CrossRef][Medline]
  40. Weins A, Kenlan P, Herbert S, Le TC, Villegas I, Kaplan BS, Appel GB, Pollak MR: Mutational and biological analysis of alpha-actinin-4 in focal segmental glomerulosclerosis. J Am Soc Nephrol 16: 3694–3701, 2005[Abstract/Free Full Text]
  41. Michaud JL, Lemieux LI, Dube M, Vanderhyden BC, Robertson SJ, Kennedy CR: Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4. J Am Soc Nephrol 14: 1200–1211, 2003[Abstract/Free Full Text]
  42. Kos CH, Le TC, Sinha S, Henderson JM, Kim SH, Sugimoto H, Kalluri R, Gerszten RE, Pollak MR: Mice deficient in alpha-actinin-4 have severe glomerular disease. J Clin Invest 111: 1683–1690, 2003[CrossRef][Medline]
  43. Sakai T, Li S, Docheva D, Grashoff C, Sakai K, Kostka G, Braun A, Pfeifer A, Yurchenco PD, Fassler R: Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev 17: 926–940, 2003[Abstract/Free Full Text]
  44. Fukuda T, Chen K, Shi X, Wu C: PINCH-1 is an obligate partner of integrin-linked kinase (ILK) functioning in cell shape modulation, motility, and survival. J Biol Chem 278: 51324–51333, 2003[Abstract/Free Full Text]

Related Article

This Month’s Highlights
J. Am. Soc. Nephrol. 2006 17: 2075-2076. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Cell Sci.Home page
P. C. McDonald, A. B. Fielding, and S. Dedhar
Integrin-linked kinase - essential roles in physiology and cancer biology
J. Cell Sci., October 1, 2008; 121(19): 3121 - 3132.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
X. Shi, H. Qu, M. Kretzler, and C. Wu
Roles of PINCH-2 in regulation of glomerular cell shape change and fibronectin matrix deposition
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F253 - F263.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
S. E. Quaggin and J. A. Kreidberg
Development of the renal glomerulus: good neighbors and good fences
Development, February 15, 2008; 135(4): 609 - 620.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Li, Y. S. Kang, C. Dai, L. P. Kiss, X. Wen, and Y. Liu
Epithelial-to-Mesenchymal Transition Is a Potential Pathway Leading to Podocyte Dysfunction and Proteinuria
Am. J. Pathol., February 1, 2008; 172(2): 299 - 308.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Y. Jung, K. Chen, M. Kretzler, and C. Wu
TGF-beta1 Regulates the PINCH-1-Integrin-Linked Kinase-{alpha}-Parvin Complex in Glomerular Cells
J. Am. Soc. Nephrol., January 1, 2007; 18(1): 66 - 73.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2006010033v1
17/8/2164    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed